Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $2.1M | $6.0M | $4.5M | $4.2M | $2.8M | $23.6M |
| Cost of revenue | $0 | $0 | $0 | $23.0M | $25.2M | $0 | $0 | $7.4M |
| Gross profit | $0 | $0 | $2.1M | −$17.1M | −$20.7M | $4.2M | $2.8M | $16.2M |
| Gross margin | — | — | 100.0% | -284.7% | -462.3% | 100.0% | 100.0% | 68.7% |
| R&D | $16.6M | $46.5M | $25.2M | $23.0M | $25.2M | $19.8M | $20.4M | $16.0M |
| Operating income | −$25.8M | −$59.8M | −$36.2M | −$28.6M | −$30.7M | −$30.2M | −$29.9M | −$35.4M |
| EBITDA | −$25.2M | −$59.8M | −$33.8M | −$26.5M | −$28.3M | −$24.1M | −$29.6M | −$28.2M |
| Net income | −$28.1M | −$59.7M | −$37.1M | −$12.7M | −$30.8M | −$30.2M | −$28.8M | −$19.6M |
| Net margin | — | — | -1734.9% | -211.5% | -687.5% | -716.8% | -1021.9% | -82.9% |
| EPS (diluted) | -25.11 | -99.73 | -23.23 | -4.91 | -11.72 | -3.05 | -1.69 | -0.89 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds NOVN.
No tracked institution reports a position in NOVN as of their last filing.
| Execution date | Ratio |
|---|---|
| 2021-05-26 | 1-for-10reverse |
No one on the platform has traded NOVN yet.
| $13M |
| — |
| MTPMidatech Pharma plc | $0.29 | -18.50% | $2M | — |
| NTBLNotable Labs, Ltd. | $0.25 | -27.68% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.